Ginkgo Bioworks (DNA) News Today $6.45 -0.47 (-6.75%) Closing price 03:59 PM EasternExtended Trading$6.60 +0.14 (+2.20%) As of 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Ginkgo Bioworks Reports First Quarter 2025 Financial ResultsMay 6 at 5:47 PM | gurufocus.comGinkgo Bioworks Reports First Quarter 2025 Financial ResultsMay 6 at 5:00 PM | prnewswire.comGinkgo Bioworks Holdings Q1 Earnings PreviewMay 5 at 9:53 PM | msn.comMarshall Wace LLP Makes New $665,000 Investment in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)Marshall Wace LLP purchased a new stake in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 67,684 shares of the company's stock, valued at apprMay 4 at 3:44 AM | marketbeat.comGinkgo Bioworks (DNA) to Release Earnings on TuesdayGinkgo Bioworks (NYSE:DNA) will be releasing its Q1 2025 earnings before the market opens on Tuesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-6-ginkgo-bioworks-holdings-inc-stock/)May 3 at 5:31 AM | marketbeat.comSusquehanna Fundamental Investments LLC Takes Position in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)Susquehanna Fundamental Investments LLC purchased a new position in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 182,925 shares of tMay 3 at 4:59 AM | marketbeat.comPDT Partners LLC Raises Stake in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)PDT Partners LLC lifted its holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA - Free Report) by 28.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 188,803 shares of the company's stock after acquiringMay 2, 2025 | marketbeat.comRenaissance Technologies LLC Acquires 45,200 Shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)Renaissance Technologies LLC grew its stake in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA - Free Report) by 65.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 114,654 shares of the company'May 2, 2025 | marketbeat.comLPL Financial LLC Decreases Position in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)LPL Financial LLC lessened its position in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA - Free Report) by 76.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 18,929 shares of the company's stock after selling 59,988 sMay 2, 2025 | marketbeat.comPhytolon and Ginkgo Bioworks Boost Natural Food Colors by Hitting Full-Project Milestone, ...April 30, 2025 | gurufocus.comPhytolon and Ginkgo Bioworks Boost Natural Food Colors by Hitting Full-Project Milestone, Nearly Tripling the Manufacturing Efficiency of Phytolon's Innovative ColorsApril 30, 2025 | prnewswire.comGinkgo Bioworks Announces Date of First Quarter 2025 Results PresentationApril 29, 2025 | prnewswire.comJump Financial LLC Purchases New Position in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)Jump Financial LLC acquired a new position in shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 51,415 shares of the company's stock, valued aApril 27, 2025 | marketbeat.comGinkgo Automation partners with Aura Genetics for diagnostic testingApril 23, 2025 | markets.businessinsider.comGinko Automation Partners with Aura Genetics to Accelerate Direct-to-Consumer Testing and InnovationApril 22, 2025 | prnewswire.comLegal & General Group Plc Decreases Stock Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)Legal & General Group Plc trimmed its position in shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA - Free Report) by 40.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 851,421 shares of the company's stock afterApril 21, 2025 | marketbeat.comVanguard Group Inc. Has $19.77 Million Position in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)Vanguard Group Inc. decreased its holdings in shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA - Free Report) by 22.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,013,558 shares of the company's stoApril 19, 2025 | marketbeat.comGinkgo Bioworks Holdings, Inc. (DNA) Stock Moves -1.94%: What You Should KnowApril 17, 2025 | msn.comReshma KewalramaniApril 16, 2025 | time.comWall Street Analysts Think Ginkgo Bioworks (DNA) Could Surge 41.59%: Read This Before Placing a BetApril 12, 2025 | uk.finance.yahoo.comGinkgo Bioworks, partners awarded $29M contract by ARPA-HApril 11, 2025 | markets.businessinsider.comGinkgo Bioworks Teams Up with Partners on ARPA-H Project to Stabilize Pharmaceutical Supply Chains - Using Amber Waves of GrainApril 10, 2025 | prnewswire.comGinkgo Bioworks Teams Up with Partners on ARPA-H Project to Stabilize Pharmaceutical Supply Chains - Using Amber Waves of GrainApril 10, 2025 | prnewswire.comPlex Research Partners With Ginkgo Bioworks on Artificial Intelligence (AI)-Powered Drug Discovery to Identify Novel Disease Mechanisms and PathwaysApril 3, 2025 | businesswire.comIs Ginkgo Bioworks Holdings, Inc. (DNA) the Best Gene-Editing Stock to Buy?April 2, 2025 | finance.yahoo.comGinkgo Bioworks falls -4.8%April 2, 2025 | markets.businessinsider.comIs Ginkgo Bioworks Holdings, Inc. (DNA) the Best Gene-Editing Stock to Buy?April 1, 2025 | insidermonkey.comBTIG Reaffirms Their Sell Rating on Ginkgo Bioworks Holdings (DNA)March 18, 2025 | markets.businessinsider.comErste Asset Management GmbH Raises Stock Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)Erste Asset Management GmbH boosted its holdings in shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA - Free Report) by 47.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 739,332 shares of the company'sMarch 15, 2025 | marketbeat.comSPX Gestao de Recursos Ltda Makes New $491,000 Investment in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)SPX Gestao de Recursos Ltda acquired a new position in shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 50,000 shMarch 11, 2025 | marketbeat.comGinkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Acquired by Prescott Group Capital Management L.L.C.Prescott Group Capital Management L.L.C. boosted its stake in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA - Free Report) by 33.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 361,750 shares of the company's stockMarch 8, 2025 | marketbeat.comVW's cheapest EV will have Rivian DNA and who is bidding for Canoo's assetsMarch 6, 2025 | techcrunch.comGinkgo Bioworks (NYSE:DNA) Shares Up 6.6% - What's Next?Ginkgo Bioworks (NYSE:DNA) Trading 6.6% Higher - Should You Buy?March 3, 2025 | marketbeat.comGinkgo Bioworks price target lowered to $12 from $16 at TD CowenFebruary 28, 2025 | markets.businessinsider.comGinkgo Bioworks (NYSE:DNA) Shares Gap Down - Should You Sell?Ginkgo Bioworks (NYSE:DNA) Shares Gap Down - Time to Sell?February 27, 2025 | marketbeat.com2025 Is Make Or Break For Ginkgo BioworksFebruary 27, 2025 | seekingalpha.comGinkgo Bioworks (DNA) to Release Quarterly Earnings on ThursdayGinkgo Bioworks (NYSE:DNA) will be releasing earnings after the market closes on Thursday, March 6. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=443042)February 27, 2025 | marketbeat.comGinkgo Bioworks (NYSE:DNA) Posts Earnings Results, Misses Expectations By $0.37 EPSGinkgo Bioworks (NYSE:DNA - Get Free Report) issued its quarterly earnings data on Tuesday. The company reported ($1.82) earnings per share for the quarter, missing the consensus estimate of ($1.45) by ($0.37). Ginkgo Bioworks had a negative return on equity of 58.54% and a negative net margin of 298.78%.February 26, 2025 | marketbeat.comGinkgo Bioworks (NYSE:DNA) Releases Earnings Results, Misses Estimates By $0.37 EPSGinkgo Bioworks (NYSE:DNA - Get Free Report) posted its quarterly earnings data on Tuesday. The company reported ($1.82) EPS for the quarter, missing the consensus estimate of ($1.45) by ($0.37). Ginkgo Bioworks had a negative return on equity of 58.54% and a negative net margin of 298.78%.February 26, 2025 | marketbeat.comGinkgo Bioworks falls -12.5%February 26, 2025 | markets.businessinsider.comGinkgo subleases part of HQ, looks to address $65M of excess spaceFebruary 26, 2025 | bizjournals.comGinkgo Bioworks options imply 17.6% move in share price post-earningsFebruary 26, 2025 | markets.businessinsider.comWilliam Blair Sticks to Its Sell Rating for Ginkgo Bioworks Holdings (DNA)February 26, 2025 | markets.businessinsider.comFlywire Posts Downbeat Results, Joins Lemonade, Ginkgo Bioworks And Other Big Stocks Moving Lower In Wednesday's Pre-Market SessionFebruary 26, 2025 | benzinga.comGinkgo Bioworks Holdings, Inc. (DNA) Q4 2024 Earnings Call TranscriptFebruary 25, 2025 | seekingalpha.comGinkgo Bioworks Holdings, Inc. 2024 Q4 - Results - Earnings Call PresentationFebruary 25, 2025 | seekingalpha.comGinkgo Bioworks Reports Fourth Quarter and Full Year 2024 Financial ResultsFebruary 25, 2025 | prnewswire.comGinkgo Bioworks (NYSE:DNA) Stock Price Down 9.3% - Should You Sell?Ginkgo Bioworks (NYSE:DNA) Stock Price Down 9.3% - Here's What HappenedFebruary 24, 2025 | marketbeat.comGinkgo Bioworks (DNA) Expected to Announce Earnings on TuesdayGinkgo Bioworks (NYSE:DNA) will be releasing earnings after the market closes on Tuesday, February 25, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=443042)February 23, 2025 | marketbeat.comGinkgo Bioworks integrates Callisto for NGS processesFebruary 22, 2025 | markets.businessinsider.com Get Ginkgo Bioworks News Delivered to You Automatically Sign up to receive the latest news and ratings for DNA and its competitors with MarketBeat's FREE daily newsletter. Email Address DNA Media Mentions By Week DNA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DNA News Sentiment▼0.680.69▲Average Medical News Sentiment DNA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DNA Articles This Week▼106▲DNA Articles Average Week Get Ginkgo Bioworks News Delivered to You Automatically Sign up to receive the latest news and ratings for DNA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Arrowhead Pharmaceuticals News Today Centessa Pharmaceuticals News Today Galapagos News Today IDEAYA Biosciences News Today Arcutis Biotherapeutics News Today Travere Therapeutics News Today Apogee Therapeutics News Today Agios Pharmaceuticals News Today Harmony Biosciences News Today Edgewise Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:DNA) was last updated on 5/6/2025 by MarketBeat.com Staff From Our Partners3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump Orders 'National Digital Asset Stockpile'Trump's tariffs on China have caused a ripple effect across global markets. But in crypto? They've lit a fu...Crypto 101 Media | SponsoredREVEALED: Elon’s Secret Master Plan “AGENDA X”REVEALED: Elon's Secret Master Plan "AGENDA X" For almost 30 years, Elon worked on his master plan in secre...Brownstone Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ginkgo Bioworks Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ginkgo Bioworks With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy DNA Stock Free DNA Stock Alerts